NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC)
CUSIP: 64130M209
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,477,622
- Total 13F shares
- 1,929,327
- Share change
- +310,809
- Total reported value
- $1,640,294
- Put/Call ratio
- 2.9%
- Price per share
- $0.85
- Number of holders
- 18
- Value change
- +$267,014
- Number of buys
- 9
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 64130M209?
CUSIP 64130M209 identifies NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 64130M209:
Top shareholders of NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MERCHANT ADVENTURE FUND, L.P. |
13D/G
|
— |
14%
|
4,200,000
|
$2,478,000 | $0 | 31 Dec 2024 | |
| AWM Investment Company, Inc. |
13D/G
13F
|
Company |
4.8%
|
2,354,167
|
$1,388,959 | $0 | 31 Mar 2025 | |
| MANCHESTER MANAGEMENT CO LLC |
13D/G
|
JAMES E. BESSER |
4.9%
|
1,583,332
|
$934,166 | $0 | 31 Dec 2024 | |
| Laurence W. Lytton |
13D/G
|
LYTTON LAURENCE W |
2.6%
|
1,295,288
|
$764,220 | $0 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
919,528
|
$759,530 | — | 31 Dec 2024 | |
| Nantahala Capital Management, LLC |
13D/G
|
— |
2.6%
|
798,762
|
$471,270 | $0 | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.7%
|
311,659
|
$257,466 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.96%
|
81,802
|
$67,560 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.7%
|
59,499
|
$49,140 | — | 31 Dec 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.66%
|
55,556
|
$45,884 | — | 31 Dec 2024 | |
| MAI Capital Management |
13F
|
Company |
0.59%
|
50,000
|
$41,295 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.47%
|
39,951
|
$32,996 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.36%
|
30,281
|
$25,009 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.22%
|
18,520
|
$15,296 | — | 31 Dec 2024 | |
| Princeton Global Asset Management LLC |
13F
|
Company |
0.2%
|
16,833
|
$13,902 | — | 31 Dec 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.15%
|
12,645
|
$10,000 | — | 31 Dec 2024 | |
| Marcum Wealth, LLC |
13F
|
Company |
0.14%
|
12,000
|
$9,911 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.07%
|
5,747
|
$4,747 | — | 31 Dec 2024 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0.03%
|
2,500
|
$2,065 | — | 31 Dec 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
1,259
|
$1,044 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
333
|
$275 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
228
|
$188 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
108
|
$89 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
66
|
$55 | — | 31 Dec 2024 | |
| Vermillion Wealth Management, Inc. |
13F
|
Company |
0%
|
3
|
$2 | — | 31 Dec 2024 |
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) as of Q1 2025
As of 31 Mar 2025,
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,929,327 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, Cambridge Investment Research Advisors, Inc., STATE STREET CORP, BLAIR WILLIAM & CO/IL, MAI Capital Management, NORTHERN TRUST CORP, J.W. COLE ADVISORS, INC., and Princeton Global Asset Management LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
20
Q1 2025 holders
18
Holder diff
-2
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.